IndraLab

Statements

Dopamine-beta-hydroxylase inhibitor inhibits KCNH2. 1 / 1

| 1

reach

"Etamicastat, a peripheral reversible dopamine-beta-hydroxylase inhibitor, blocked the hERG current amplitude with an IC50 value of 44.0 microg/ml in HEK 293 cells."

25641747

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Dopamine-beta-hydroxylase inhibitor inhibits KCNH2. 1 / 1

INDRA sources:

Databases

Reading